+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-01-06Number of Pages: 178

Psoriasis Treatment Market (Product - TNF Inhibitors, Vitamin D Analogues or Combinations, and Interleukin Blockers; Therapy - Topical Therapeutic Drugs, Systemic Therapeutic Drugs, and Combinations; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology 
     2.1. Assumptions     
     2.2. Research Methodology

3. Executive Summary
     3.1. Global Psoriasis Treatment Market Snapshot
     3.2. Market Share Analysis by Region, 2015
     3.3. Global Psoriasis Treatment Market : Opportunity Map

4. Market Overview
     4.1. Product Overview
     4.2. Global Psoriasis Treatment Market : Key Industry Events
     4.3. Global Psoriasis Treatment Market Size (US$ Mn) Forecast, 2014–2024
     4.4. Psoriasis Treatment Market Outlook
     4.5. Global Psoriasis Treatment Supply Demand Scenario 
     4.6. Porter’s Analysis 

5. Market Dynamics
     5.1. Drivers
           5.1.1. Approval of new biologics
           5.1.2. Increase in access for treatment in developing markets 
           5.1.3. Novel Pipeline Drugs
           5.1.4. Increase in the number of psoriasis patients
     5.2. Restrains
           5.2.1. Loss of response to current therapies
           5.2.2. Premium-priced biologics
     5.3. Opportunities
           5.3.1. Newer modalities and availability of predictive biomarkers, offer opportunity of personalized treatment for psoriasis
           5.3.2. Specialty biologics set to lose their exclusivity status
     5.4. Key Trends
           5.4.1. Increasing cost of psoriasis biologics
           5.4.2. The number of physicians that practice independently has been declining

6. Psoriasis Treatment Market Analysis, by Product Type
     6.1. Key Findings
     6.2. Introduction
     6.3. Global Psoriasis Treatment Market Value Share Analysis, by Product Type
     6.4. Psoriasis Treatment Market Analysis, by Product Type 
           6.4.1. TNF Inhibitors
           6.4.2. Vitamin D Analogues or Combinations
           6.4.3. Interleukin Blockers
           6.4.4. Others
     6.5. Psoriasis Treatment Market Attractiveness Analysis, by Product Type 
     6.6. Key Trends

7. Psoriasis Treatment Market Analysis, by Therapy
     7.1. Key Findings
     7.2. Introduction
     7.3. Global Psoriasis Treatment Market Value Share Analysis, by Therapy
     7.4. Psoriasis Treatment Market Analysis, by Therapy
           7.4.1. Topical Therapeutic Drugs
           7.4.2. Systemic Therapeutic Drugs
           7.4.3. Combinations & Others
     7.5. Psoriasis Treatment Market Attractiveness Analysis, by Therapy
     7.6. Key Trends

8. Psoriasis Treatment Market Analysis, by Distribution Channel
     8.1. Key Findings
     8.2. Introduction
     8.3. Global Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     8.4. Psoriasis Treatment Market Analysis, by Distribution Channel
           8.4.1. Hospital Pharmacy
           8.4.2. Retail Pharmacy
           8.4.3. Online Sales
     8.5. Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
     8.6. Key Trends

9. Psoriasis Treatment Market Analysis, by Region
     9.1. Global Psoriasis Treatment Market Snapshot, by Country
     9.2. Global Psoriasis Treatment Market Value Share Analysis, by Region
     9.3. Psoriasis Treatment Market Forecast, by Region
     9.4. Psoriasis Treatment Market Attractiveness Analysis, by Region

10. North America Psoriasis Treatment Market Analysis
     10.1. Key Findings
     10.2. North America Psoriasis Treatment Market Overview
     10.3. North America Market Value Share Analysis, by Product
     10.4. North America Market Forecast, by Product
           10.4.1. TNF Inhibitors
           10.4.2. Vitamin D Analogues or Combinations
           10.4.3. Interleukin Blockers
           10.4.4. Others
     10.5. North America Market Value Share Analysis, by Therapy
     10.6. North America Market Forecast, by Therapy
           10.6.1. Topical Therapeutic Drugs
           10.6.2. Systemic Therapeutic Drugs
           10.6.3. Combinations & Others 
     10.7. North America Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     10.8. North America Market Forecast, by Distribution Channel
           10.8.1. Hospital Pharmacy
           10.8.2. Retail Pharmacy
           10.8.3. Online Sales 
     10.9. Market Analysis, by Country
     10.10. Market Value Share Analysis, by Country
     10.11. Market Size (US$ Mn) Forecast, by Country, 2016–2024
           10.11.1. U.S.
           10.11.2. Canada
     10.12. Market Attractiveness Analysis
           10.12.1. By Product
           10.12.2. By Therapy
           10.12.3. By Distribution Channel
           10.12.4. By Country
     10.13. Market Trends

11. Europe Psoriasis Treatment Market Analysis
     11.1. Key Findings
     11.2. Europe Psoriasis Treatment Market Overview
     11.3. Europe Market Value Share Analysis, by Product
     11.4. Europe Market Forecast, by Product
           11.4.1. TNF Inhibitors
           11.4.2. Vitamin D Analogues or Combinations
           11.4.3. Interleukin Blockers
           11.4.4. Others
     11.5. Europe Market Value Share Analysis, by Therapy
     11.6. Europe Market Forecast, by Therapy
           11.6.1. Topical Therapeutic Drugs
           11.6.2. Systemic Therapeutic Drugs
           11.6.3. Combinations & Others 
     11.7. Europe Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     11.8. Europe Market Forecast, by Distribution Channel
           11.8.1. Hospital Pharmacy
           11.8.2. Retail Pharmacy
           11.8.3. Online Sales 
     11.9. Market Analysis, by Country
     11.10. Market Value Share Analysis, by Country
     11.11. Market Size (US$ Mn) Forecast, by Country, 2016–2024
           11.11.1. Germany
           11.11.2. U.K.
           11.11.3. Spain
           11.11.4. Italy
           11.11.5. France
           11.11.6. Rest of Europe
     11.12. Market Attractiveness Analysis
           11.12.1. By Product
           11.12.2. By Therapy
           11.12.3. By Distribution Channel
           11.12.4. By Country
     11.13. Market Trends

12. Asia Pacific Psoriasis Treatment Market Analysis
     12.1. Key Findings
     12.2. Asia Pacific Psoriasis Treatment Market Overview
     12.3. Asia Pacific Market Value Share Analysis, by Product
     12.4. Asia Pacific Market Forecast, by Product
           12.4.1. TNF Inhibitors
           12.4.2. Vitamin D Analogues or Combinations
           12.4.3. Interleukin Blockers
           12.4.4. Others
     12.5. Asia Pacific Market Value Share Analysis, by Therapy
     12.6. Asia Pacific Market Forecast, by Therapy
           12.6.1. Topical Therapeutic Drugs
           12.6.2. Systemic Therapeutic Drugs
           12.6.3. Combinations & Others 
     12.7. Asia Pacific Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     12.8. Asia Pacific Market Forecast, by Distribution Channel
           12.8.1. Hospital Pharmacy
           12.8.2. Retail Pharmacy
           12.8.3. Online Sales 
     12.9. Market Analysis, by Country
     12.10. Market Value Share Analysis, by Country
     12.11. Market Size (US$ Mn) Forecast, by Country, 2016–2024
           12.11.1. Japan
           12.11.2. China
           12.11.3. Australia & New Zealand
           12.11.4. India
           12.11.5. Rest of Asia Pacific
     12.12. Market Attractiveness Analysis
           12.12.1. By Product
           12.12.2. By Therapy
           12.12.3. By Distribution Channel
           12.12.4. By Country
     12.13. Market Trends

13. Latin America Psoriasis Treatment Market Analysis
     13.1. Key Findings
     13.2. Latin America Psoriasis Treatment Market Overview
     13.3. Latin America Market Value Share Analysis, by Product
     13.4. Latin America Market Forecast, by Product
           13.4.1. TNF Inhibitors
           13.4.2. Vitamin D Analogues or Combinations
           13.4.3. Interleukin Blockers
           13.4.4. Others
     13.5. Latin America Market Value Share Analysis, by Therapy
     13.6. Latin America Market Forecast, by Therapy
           13.6.1. Topical Therapeutic Drugs
           13.6.2. Systemic Therapeutic Drugs
           13.6.3. Combinations & Others 
     13.7. Latin America Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     13.8. Latin America Market Forecast, by Distribution Channel
           13.8.1. Hospital Pharmacy
           13.8.2. Retail Pharmacy
           13.8.3. Online Sales 
     13.9. Market Analysis, by Country
     13.10. Market Value Share Analysis, by Country
     13.11. Market Size (US$ Mn) Forecast, by Country, 2016–2024
           13.11.1. Brazil
           13.11.2. Mexico
           13.11.3. Rest of Latin America
     13.12. Market Attractiveness Analysis
           13.12.1. By Product
           13.12.2. By Therapy
           13.12.3. By Distribution Channel
           13.12.4. By Country
     13.13. Market Trends

14. Middle East & Africa Psoriasis Treatment Market Analysis
     14.1. Key Findings
     14.2. Middle East & Africa Psoriasis Treatment Market Overview
     14.3. Middle East & Africa Market Value Share Analysis, by Product
     14.4. Middle East & Africa Market Forecast, by Product
           14.4.1. TNF Inhibitors
           14.4.2. Vitamin D Analogues or Combinations
           14.4.3. Interleukin Blockers
           14.4.4. Others
     14.5. Middle East & Africa Market Value Share Analysis, by Therapy
     14.6. Middle East & Africa Market Forecast, by Therapy
           14.6.1. Topical Therapeutic Drugs
           14.6.2. Systemic Therapeutic Drugs
           14.6.3. Combinations & Others 
     14.7. Middle East & Africa Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     14.8. Middle East & Africa Market Forecast, by Distribution Channel
           14.8.1. Hospital Pharmacy
           14.8.2. Retail Pharmacy
           14.8.3. Online Sales 
     14.9. Market Analysis, by Country
     14.10. Market Value Share Analysis, by Country
     14.11. Market Size (US$ Mn) Forecast, by Country, 2016–2024
           14.11.1. South Africa
           14.11.2. Saudi Arabia
           14.11.3. Rest of Middle East & Africa
     14.12. Market Attractiveness Analysis
           14.12.1. By Product
           14.12.2. By Therapy
           14.12.3. By Distribution Channel
           14.12.4. By Country
     14.13. Market Trends

15. Company Profiles
     15.1. Psoriasis Treatment Market Share Analysis, by Company (2015)
     15.2. Competition Matrix
     15.3. Company Profiles
           15.3.1. Amgen, Inc.
                    15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.1.2. Financial Overview
                    15.3.1.3. Product Portfolio
                    15.3.1.4. SWOT Analysis
                    15.3.1.5. Strategic Overview
           15.3.2. Eli Lilly & Company
                    15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.2.2. Financial Overview
                    15.3.2.3. Product Portfolio
                    15.3.2.4. SWOT Analysis
                    15.3.2.5. Strategic Overview
           15.3.3. Novartis AG
                    15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.3.2. Financial Overview
                    15.3.3.3. Product Portfolio
                    15.3.3.4. SWOT Analysis
                    15.3.3.5. Strategic Overview
           15.3.4. Merck & Co., Inc.
                    15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.4.2. Financial Overview
                    15.3.4.3. Product Portfolio
                    15.3.4.4. SWOT Analysis
                    15.3.4.5. Strategic Overview
           15.3.5. Johnson & Johnson
                    15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.5.2. Financial Overview
                    15.3.5.3. Product Portfolio
                    15.3.5.4. SWOT Analysis
                    15.3.5.5. Strategic Overview
           15.3.6. Pfizer, Inc.
                    15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.6.2. Financial Overview
                    15.3.6.3. Product Portfolio
                    15.3.6.4. SWOT Analysis
                    15.3.6.5. Strategic Overview
           15.3.7. AstraZeneca 
                    15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.7.2. Financial Overview
                    15.3.7.3. Product Portfolio
                    15.3.7.4. SWOT Analysis
                    15.3.7.5. Strategic Overview
           15.3.8. AbbVie, Inc.
                    15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.8.2. Financial Overview
                    15.3.8.3. Product Portfolio
                    15.3.8.4. SWOT Analysis
                    15.3.8.5. Strategic Overview
           15.3.9. LEO Pharma A/S
                    15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.9.2. Financial Overview
                    15.3.9.3. Product Portfolio
                    15.3.9.4. SWOT Analysis
                    15.3.9.5. Strategic Overview
           15.3.10. Biogen
                    15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.10.2. Financial Overview
                    15.3.10.3. Product Portfolio
                    15.3.10.4. SWOT Analysis
                    15.3.10.5. Strategic Overview

List of Figures

Figure 1: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, 2014–2024
Figure 2: Global Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 3: Global TNF Inhibitors Market Revenue (US$ Mn), 
Figure 4: Global Vitamin D Analogues or Combinations Market Revenue (US$ Mn), 2014–2024
Figure 5: Global Interleukin Blockers Market Revenue (US$ Mn), 2014–2024
Figure 6: Global Others Market Revenue (US$ Mn), 2014–2024
Figure 7: Psoriasis Treatment Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 8: Global Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 9: Global Topical Therapeutic Drugs Market Revenue (US$ Mn), 2014–2024
Figure 10: Global Systemic Therapeutic Drugs Market Revenue (US$ Mn), 2014–2024
Figure 11: Global Combinations & Others Market Revenue (US$ Mn), 2014–2024
Figure 12: Psoriasis Treatment Market Attractiveness Analysis, by Therapy, 2016–2024
Figure 13: Global Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 14: Global Hospital Pharmacy Market Revenue (US$ Mn), 2014–2024
Figure 15: Global Retail Pharmacy Market Revenue (US$ Mn), 2014–2024
Figure 16: Global Online Sales Market Revenue (US$ Mn), 2014–2024
Figure 17: Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 18: Global Psoriasis Treatment Market Value Share, by Region, 2016 and 2024
Figure 19: Psoriasis Treatment Market Attractiveness Analysis, by Region, 2016–2024
Figure 20: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016–2024
Figure 21: North America Market Attractiveness Analysis, 
Figure 22: North America Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 23: North America Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 24: North America Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 25: North America Psoriasis Treatment Market Value Share Analysis, by Country, 2016 and 2024
Figure 26: North America Psoriasis Treatment Market Attractiveness Analysis, by Product
Figure 27: North America Psoriasis Treatment Market Attractiveness Analysis, by Therapy
Figure 28: North America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
Figure 29: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016–2024
Figure 30: Europe Market Attractiveness Analysis, 
Figure 31: Europe Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 32: Europe Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 33: Europe Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 34: Europe Psoriasis Treatment Market Value Share, by Country, 2016 and 2024
Figure 35: Europe Psoriasis Treatment Market Attractiveness Analysis, by Product
Figure 36: Europe Psoriasis Treatment Market Attractiveness Analysis, by Therapy
Figure 37: Europe Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
Figure 38: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016–2024
Figure 39: Asia Pacific Market Attractiveness Analysis, 
Figure 40: Asia Pacific Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 41: Asia Pacific Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 42: Asia Pacific Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 43: Asia Pacific Psoriasis Treatment Market Value Share, by Country, 2016 and 2024
Figure 44: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Product
Figure 45: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Therapy
Figure 46: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
Figure 47: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016–2024
Figure 48: Latin America Market Attractiveness Analysis,
Figure 49: Latin America Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 50: Latin America Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 51: Latin America Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 52: Latin America Market Value Share Analysis, by Country, 2016 and 2024
Figure 53: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Product
Figure 54: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Therapy
Figure 55: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
Figure 56: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016–2024
Figure 57: Middle East & Africa Market Attractiveness Analysis, 
Figure 58: Middle East & Africa Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 59: Middle East & Africa Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 60: Middle East & Africa Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 61: Middle East & Africa Market Value Share, by Country, 2016 and 2024
Figure 62: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Product
Figure 63: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Therapy
Figure 64: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
Figure 65: Global Psoriasis Treatment Market Share Analysis, by Company (2015)

List of Tables

Table 1: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 2: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 3: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 4: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 5: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 6: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 7: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 8: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 9: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 10: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 11: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 12: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 13: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 14: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 15: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 16: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 17: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 18: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 19: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 20: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 21: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 22: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 23: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 24: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024


 
 
Back To Top